Awards & Advancement

EMD Serono appoints U.S. CMO

Wednesday, September 30, 2015

EMD Serono, the U.S. biopharmaceutical business of Germany-based Merck, has appointed Joseph Leveque, M.D., as U.S. chief medical officer. Leveque will be responsible for working with the regulatory, medical and development teams to enhance EMD Serono’s clinical presence in the U.S. and to drive the execution of crucial medical initiatives.

[Read More]

Exelixis adds top personnel

Monday, September 28, 2015

Exelixis has announced three high-level appointments as the company prepares for the potential commercialization of its lead compound, cabozantinib, for the treatment of advanced renal cell carcinoma (RCC) following positive results from the METEOR pivotal phase III trial. William Berg, M.D., has joined the company as senior vice president of medical affairs, Jonathan Berndt as vice president of sales, and Gregg Bernier as vice president of marketing.

[Read More]

Albireo appoints Cooper as CEO

Thursday, September 24, 2015

Ron Cooper has joined Albireo, a privately held company focused through its operating subsidiary on the development of bile acid modulators to treat orphan pediatric and adult liver diseases, NASH and gastrointestinal disorders, as president and chief executive officer.

[Read More]

ERT reports rapid growth with Insights Cloud

Monday, September 21, 2015

ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, has experienced record growth in its ERT Insights Cloud solution—a suite of data analytics visualization and workflow applications for use in pharmaceutical clinical development.

[Read More]

PPD receives digital communications awards

Thursday, September 17, 2015

Pharmaceutical Product Development (PPD) has earned recognition for excellence in multimedia and digital communications that promote the people and technology vital to advancing the development of life-changing medicines. PPD earned five honors in the annual Telly Awards and three in the Digital Health Awards.

[Read More]

Biogen named Global Biotechnology Industry Leader

Monday, September 14, 2015

Biogen, based in Cambridge, Mass., has been named the biotechnology industry leader on the Dow Jones Sustainability World Index (DJSI World) for the second year in a row, after becoming the first U.S.-based biotech company to make the list in 2013. The company also was named to the Dow Jones Sustainability Index North America for the sixth consecutive year, one of only three biotech companies included.

[Read More]